KUALA LUMPUR: Pharmaniaga Bhd
's wholly owned subsidiary Pharmaniaga Research Centre Sdn Bhd has entered into a memorandum of understanding with the National Institutes of Biotechnology Malaysia (NIBM) to collaborate on vaccine research and development.
It said in a filing with Bursa Malaysia that the MoU shall come into effect from Nov 1, 2021, and shall remain in force for a period of three years or until termination of the MoU, whichever is earlier.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
